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STRUCTURED ABSTRACT 
Aims  
To detect possible autonomic changes due to home orthostatic training (HOT) and to assess the 
feasibility of a larger, placebo-controlled study of HOT in vasovagal syncope (VVS). 
Method 
22 consecutive patients, aged 18 to 85, diagnosed with VVS following a positive head-up tilt-table 
test were randomized to 40 minutes’ HOT (n=12) or 10 minutes’ sham training (n=10) daily for six 
months. Baroreflex sensitivity (BRS) and heart rate variability (HRV) were measured at weeks 0, 1, 
4 and 24. Symptom response was assessed by event diaries. 
Results 
Home orthostatic training resulted in increases in up and down slope BRS at week 4 (elog 
difference
=1.59;95%confidence interval(CI)=0.84,3.03 and 1.79;95%CI=1.00,3.22) and week 24 (elog 
difference
=1.75;95%CI=1.01,3.06 and 1.53;95%CI=0.66,2.68) compared to placebo. Relative 
improvements in low and high frequency HRV were also observed in the HOT group compared to 
placebo at week 4 (elog difference =3.22;95%CI=1.06,9.86 and 3.19;95%CI=1.03,10.59) and week 24 
(elog difference 2.11;95%CI=0.72,6.17 and 2.13;95%CI=0.52,8.79). Fifty percent of HOT subjects and 
20% of control subjects were syncope-free at 6 months.   
Conclusions 
This was the first placebo-controlled study in orthostatic training which has demonstrated that such 
a study is indeed feasible. An enhancement in overall autonomic tone is observed with HOT in 
tandem with a non-significant trend in symptom improvement. A larger, adequately powered, 
randomized, controlled trial of tilt-training is now needed. 
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CONDENSED ABSTRACT 
Serial measurements of baroreflex sensitivity (BRS) and heart rate variability (HRV) were 
conducted in 22 patients with vasovagal syncope (VVS) randomized to daily home orthostatic 
training or placebo over six months. Home orthostatic training was associated with increased 
overall HRV and BRS in tandem with non-significant improvements in symptoms. 
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INTRODUCTION 
Vasovagal syncope (VVS) is the commonest cause of transient loss of consciousness, accounting 
for 40% of syncopal episodes presenting to the emergency department 1. It was previously assumed 
to be rare in older adults but has been diagnosed with increasing frequency since the head-up tilt-
table (HUT) test was described in 1986 2, 3. While VVS in most patients either occurs infrequently 
or responds well to conservative measures, many patients continue to have persistent symptoms. 
The treatment options for the latter group of individuals are currently limited, with the recent 
randomized, controlled trials involving beta-adrenergic receptor blockers 4 and permanent cardiac 
pacemakers 5, 6 being negative. 
 
 Tilt-training or orthostatic training has been advocated as a possible effective treatment for 
VVS. There have been a handful of small, uncontrolled studies demonstrating promising results, 
though there were large variations in methodologies between the studies which included both 
formal tilt-table training and informal home orthostatic training 7-12. The randomized, controlled 
studies published so far did not show any beneficial effects for tilt-training probably due to poor 
compliance 13-16. In addition, control subjects in these studies were randomized to conventional 
treatment, not placebo. The haemodynamic effects and mechanisms of action of tilt-training have 
never been studied in the context of a randomized, controlled trial. Despite this lack of good quality 
evidence, tilt-training is recommended by consensus guidelines as a treatment for VVS 3, 17, 18.  
 
Our aim was to conduct the first randomized, placebo (sham)-controlled study of home 
orthostatic training (HOT) in vasovagal syncope. The objectives of this study were firstly, to 
determine the changes in autonomic function in response to orthostatic training; and secondly, to 
explore the feasibility of conducting such a study in order to inform a future large scale, multi-
centre study.  
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METHODS 
Subjects 
Consecutive patients aged 18 years and over diagnosed with VVS following a positive HUT test 
were invited to participate in the study if they had a symptom burden of 2 episodes of syncope; or 1 
episode of syncope with 3 episodes of presyncope; or 5 episodes of presyncope within the previous 
six months. A positive HUT test was defined as a reduction of blood pressure and/or heart rate 
during HUT with reproduction of original symptoms 18. The exclusion criteria were: (i) inability to 
provide informed consent; (ii) inability to stand for 40 minutes according to clinical judgment; (iii) 
inability to temporarily discontinue cardioactive medications for autonomic function testing; and 
(iv) pregnancy.  
 
Interventions 
Written informed consent was obtained from all participants, and they continued to receive routine 
clinical care which included lifestyle modification advice. Restricted randomization using computer 
generated random numbers was performed by an independent investigator. The treatment 
allocations were concealed in opaque, sealed envelopes. The physical treatments were demonstrated 
to the participants during their first visit. Participants were then asked to continue their training 
once daily at home for six months. Participants and clinicians providing routine clinical care were 
blinded to the randomization.  
 
HOT Therapy 
Participants within this arm were asked to stand with their upper backs against a wall and their 
heels approximately 15 centimeters (cm) from the wall with a cushioned “drop zone”. They were 
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asked to maintain this position without movement for up to 40 minutes or until they experienced 
prodromal symptoms, presyncope or syncope.  
 
Sham Training 
Participants were asked to stand against a wall as described above, but to do so for only 10 minutes. 
They were also taught to perform gentle flexion and extension exercises with their calf muscles 
while standing against the wall, in order to enhance believability, counter venous pooling and 
prevent any possible orthostatic training effect. 
 
Measurements 
Haemodynamic and Autonomic Parameters 
During each of these visits, autonomic function was assessed with heart rate variability (HRV) and 
baroreflex sensitivity (BRS) at enrolment and at one week, four weeks and six months after 
enrolment. All haemodynamic measurements were conducted in the morning. Participants were 
asked to refrain from caffeinated beverages on the day of the test. Following a 10-minute period of 
supine rest for stabilization, continuous ECG and non-invasive beat-to-beat blood pressure 
measurements were obtained using a vascular unloading device (Taskforce™, CNSystems, 
Austria). 
Heart rate variability  
Continuous ECG was recorded during 10-minutes’ supine rest with spontaneous breathing. Ectopics 
and artefacts were removed by automated software, and manually if necessary. Low frequency: 
0.04-0.15Hz (LF) and high frequency: 0.15-0.4Hz (HF) power spectral densities for at least 250 
beats of artefact free segments were calculated using the autoregressive method for HRV 19.   
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Baroreflex Sensitivity 
Baroreflex sensitivity (BRS) was determined during 10 minutes of supine rest by the sequence 
method. The slope of regression was determined for increases in systolic blood pressure (SBP) 
accompanied by lengthening of the R-R interval (RRI) (up sequences) and decreases in SBP 
associated with shortening of the RRI (down sequences) for three or more consecutive R-waves 20. 
The blood pressure sequences were paired with the RRI at which the changes occurred (lag 0).  
 
Symptom and training diaries 
All participants were asked to complete a daily event diary throughout the six months’ training 
period. They were asked to record whether training had been performed; the length of time trained 
each day, the presence of symptoms during training, as well as the presence of actual daily 
symptoms. To encourage compliance with diary and training exercises, all participants were 
contacted by telephone on a weekly basis. Information from the diaries was analyzed by an 
independent data interpreter blinded to the treatment group.  
 
Data Analysis 
All continuous variables were reported as mean with standard deviation for normally distributed 
data and median with interquartile range for non-normally distributed data. All categorical data 
were reported as number of subjects with percentages in parentheses. For the haemodynamic 
variables measured during clinic visits, comparisons were made between groups for the changes in 
LF-HRV, HF-HRV, up BRS and down BRS from baseline to week 4 and baseline to week 24, 
using the independent t-test. Low frequency heart rate variability, HF-HRV, up slope BRS and 
down slope BRS were first natural logarithmically transformed to form normal distributions before 
calculating the differences of the logged variables between week 4 and baseline as well as week 24 
and baseline. The exponential values for mean differences of the logarithmic values (elog difference), 
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with 95% confidence intervals, were subsequently presented.  The anti-log of mean differences 
therefore represent the ratio of the differences between logarithmic values of each variable for HOT 
and placebo (change ratio), thus a value of 1 indicates no difference between HOT and placebo. 
Syncope-free survival between the two groups was compared with the χ2 test. A two-tailed p-value 
of <0.05 was considered statistically significant and no adjustments were made for multiple testing. 
All data analysis was performed using SPSSTM 15.0 for Windows.  
  
Our study was intended to be a pilot study, and hence did not have adequate power to detect 
a significant change in the primary outcome measure of syncope recurrence. The number of 
subjects who remained syncope-free throughout the follow-up period and the median number of 
days with syncope were reported. Blinding of the study was assessed by asking participants whether 
they were able to guess which arm of the study they thought they were allocated to at the end of six 
months’ training. 
  
This study was granted a favorable ethical opinion by the Local Research Ethics Committee.  
 
RESULTS 
Recruitment 
Two hundred and thirty-one HUT tests were performed at our specialist syncope facility from 
September 2006 to July 2007, of which 95 were positive. Fifty-four (57%) met the study criteria, 
and were invited to participate in the study (Figure 1).  
 
Twenty-two (41%) subjects, aged 18 to 85 years, agreed to participate in the study. Twelve 
participants were randomized to HOT therapy, and the remaining 10 participants were randomized 
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to placebo. Two subjects, one in each arm, withdrew from the study, and one subject in each arm 
was lost to subsequent follow-up. One subject in the placebo arm discovered she was at the early 
stages of pregnancy at six months and therefore did not have haemodynamic measurements at the 
end of the study. Clinical and haemodynamic characteristics of the participants in our study are 
summarized in Table 1.  
 
Autonomic Cardiovascular Reflexes 
 
Baroreflex Sensitivity 
Both up slope and down slope BRS increased with HOT training compared to sham training (Figure 
2). The improvements from baseline observed with HOT compared to placebo for up slope BRS 
was non-statistically significant at week 4 (elog difference =1.59, 95%CI=0.84 to 0.84 to 3.03) but 
statistically significant at week 24 (elog difference =1.75, 95% CI=1.01 to 3.06). Down slope BRS also 
showed larger improvements over baseline for HOT compared to placebo at week 4 (elog difference 
=1.79, 95%CI=1.00 to 3.22) and week 24 (elog difference =1.53, 95% CI=0.88 to 2.68) (Table 2).  
Heart Rate Variability 
The changes in LF-HRV and HF-HRV in response to HOT and sham training are depicted 
graphically in Figure 3.  Both LF-HRV and HF-HRV improved with HOT but not sham training.  
The elog difference between HOT and placebo for the change ratio in LF-HRV from baseline was 3.22 
(95% confidence interval (CI) =1.06 to 9.86) for week 4 and 2.11 (95%CI=0.72 to 6.17) for week 
24. The elog difference for the change ratio in HF-HRV was 3.19 (95%CI=1.03 to 10.59) for week 4 
and 2.13 (95%CI=0.52, 8.79) (Table 2).  
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Symptom and Training Diaries 
Symptom diaries were returned by 10 subjects in the HOT group and 7 subjects in the sham training 
group. The median number of minutes per session trained was 10 (8 to 10) for the control group and 
25 (18 to 35) for the HOT group. Five (50%) of subjects in the placebo arm and 6 (50%) of subjects 
in the intervention arm, reported having trained for more than 50% of the time. Four (40%) 
participants in the control arm and four (30%) of subjects in the intervention arm reported 
symptoms of presyncope or syncope during training, but no injuries were sustained. 
 
 Five out of seven (71%) subjects reported syncope recurrence in the placebo arm, compared 
to 4/10 (40%) subjects in the intervention arm.  Two of the ten subjects (20%) in the control arm, 
and 6/12 (50 %) in the intervention arm were known to be syncope free at the end of 6 months, but 
this observed difference was not statistically significant (p=0.201). The median number of days 
with syncope reported by subjects throughout the trial period was 1 (0 to 2) for the sham training 
group and 0 (0 to 4) for the HOT group.  
 
Blinding 
Only 3/10 (30%) subjects who completed the study in the HOT group and 2/8 (25%) subjects in the 
sham training group correctly identified the treatment group they were randomized to.  
 
DISCUSSION 
Our study was the first placebo-controlled pilot study involving orthostatic training in vasovagal 
syncope, and the first to involve serial assessments of autonomic cardiovascular reflexes in 
response to orthostatic training. Improvements were observed in BRS using the sequence method in 
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response to HOT when compared to placebo throughout the study. Similar improvements were also 
observed for the frequency domain heart rate variability parameters of LF-HRV and HF-HRV. Our 
results, therefore, indicate that HOT increases overall autonomic tone with significant increases in 
parasympathetic and sympathetic activity, as well as BRS within 4 weeks of daily orthostatic 
training.  
 
 Traditionally, clinical assessment of autonomic function involves the assessment of blood 
pressure and heart rate changes in response to a series of physical maneuvers including active 
standing 21. The battery of tests mentioned above has relatively poor reproducibility, and is only 
sensitive to gross changes in autonomic function. Newer, more sensitive measures of autonomic 
function based on spontaneous variations in heart rate and blood pressures are now widely used as 
research tools 19, 22. Regular physiological changes in heart rate occur at rest in normal, healthy 
individuals. When the heart rate is plotted against time, these changes follow regular patterns 
appearing as oscillations, and can be separated into oscillations of varying frequencies. Changes in 
heart rate during normal breathing appear as oscillations within the HF range and therefore 
represent parasympathetic function. Oscillations in the LF range are considered a marker of 
sympathetic function, but there are controversies about the relative contribution of the 
parasympathetic system.  The steepness of the slope of increase (up slope) or decrease (down slope) 
in SBP corresponding to increases or decreases of 3 or more consecutive heart beats at rest is a 
measure of baroreflex response (the sequence method) 22. Heart rate variability and BRS are highly 
sensitive measures, with increments occurring in an exponential rather than linear fashion.  
 
Few previous studies have addressed the likely mechanisms of action underlying the 
possible beneficial effects of tilt-training or orthostatic training. Verheyden et al 12 recently 
published the results of an uncontrolled study which demonstrated an improvement in 
vasoconstrictor reserve with initial in-hospital tilt-training followed by six weeks of home 
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orthostatic training, using digital estimations of cardiac stroke volume. The authors also found a 
significant increase in LF-HRV at the reference point of syncope during HUT 12.  Piccirillo et al  23 
reported an increase in LF-HRV and BRS associated with tilt-training, but only in late rather than 
early responders in their study which mainly addressed the predictors of responders versus non-
responders. This increase in LF-HRV was not confirmed by Gajek et al 24 who found increases in 
HF-HRV at rest and during HUT following a period of tilt-training, but no changes in LF-HRV. 
The results of our study suggest that, when compared to a placebo control group, improvements 
occur in LF-HRV, HF-HRV and BRS following orthostatic training. In addition to providing 
insights into the mechanism of action of tilt-training, serial measurements of HRV and BRS will 
also serve well as a highly sensitive secondary outcome measure for future trials. Heart rate 
variability and BRS could also be useful tests to clinicians and patients as markers of treatment 
response, which will both encourage adherence and guide treatment decisions.  
 
The pathogenesis of VVS at present remains unconfirmed, with conflicting findings 
emerging from the published literature. The susceptibility to tilt-induced syncope appears to be 
associated with inadequate sympathetic activation 25, resulting in a reduction in sympathetically-
mediated peripheral vascular resistance 26. Several studies have demonstrated a reduction in BRS at 
rest or an exaggerated drop in BRS during HUT in individuals with VVS 26. Reports on HRV have 
been conflicting, but appear to consistently suggest a lower of increase in LF-HRV during HUT in 
vasovagal syncope patients with a positive response to HUT 27. Jardine et al 28 also reported a 
greater reduction in HF-HRV immediately after assuming the upright position, in HUT positive 
subjects 28. Our findings therefore suggest that this depressed BRS and HRV response could be 
corrected using the safe and simple non-pharmacological intervention of orthostatic training. These 
physiological changes also raise the possibility of an intriguing inverse relationship with space 
physiology. Astronauts acquire an increased susceptibility to syncope on return to earth. The effects 
of zero gravity appear to result in reduced BRS and absolute values of HRV on landing day 29.  
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 Several uncontrolled studies have advocated in-hospital tilt-training and home orthostatic 
training as effective treatments for refractory VVS 7-11. More recently, a handful of small, single-
centre, randomized-controlled trials have reported lack of efficacy for tilt-training due to poor 
compliance 13-16. The subjects in the control arm of the above studies were, however, randomized to 
conventional treatment, not placebo. With the serial publication of four negative randomized, 
controlled trials in the last few years, should we now conclude that tilt-training is ineffective?  The 
outcome measures reported by previous studies included time to positivity during subsequent HUT 
tests and syncope recurrence. Head-up tilt tests have low reproducibility and are of limited value as 
a test of clinical efficacy for therapeutic interventions 30. Furthermore, spontaneous syncope is a 
relatively infrequent symptom in sufferers of VVS. Many patients also experience spontaneous 
resolution of symptoms with minimal or no medical intervention. Therefore, large studies with 
prolonged follow-up periods are required in order to detect significant reductions in syncope 
recurrence.  
 
While conservative measures suffice for the majority of patients with VVS, a small number 
of patients continue to have refractory or malignant VVS for which treatment options are woefully 
inadequate. A handful of pharmacological treatments have been tested, but few have been subjected 
to the rigors of large randomized, placebo-controlled trials 17. The only multi-centre placebo-
controlled study involving metoprolol, a beta-adrenoreceptor antagonist, has been negative 4. Two 
multi-centre placebo controlled studies of permanent cardiac pacing in subjects with VVS have also 
been negative 4-6. There is therefore an urgent need for new evidence-based treatment options for 
sufferers of recurrent VVS. Home orthostatic training provides an easily performed, non-invasive 
and side-effect free alternative to drug and pacing treatment with an inadequate evidence base.  
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 Our feasibility study has first demonstrated that a placebo-controlled study of home 
orthostatic training is indeed feasible and second that HOT has a sound physiological basis, 
significantly improving autonomic tone. Our study included subjects from a broad age range, and is 
therefore unique in its inclusion of elderly subjects, who have so far rarely been considered in 
studies involving tilt-training or any other form of treatment for VVS 3. Subjects in the intervention 
arm of our study were 2.5 times more likely to be syncope free than subjects in the placebo arm, but 
this difference in actual numbers was not statistically significant, as our study was not powered to 
detect significant differences in symptom outcomes. The selection of study participants in a future 
study will be vital, as subjects with lower symptom burdens and higher likelihood of spontaneous 
recovery are neither likely to benefit from nor comply with such an arduous treatment 13.  
 
CONCLUSION 
Our study was the first ever randomized, placebo controlled trial for HOT in VVS. Orthostatic 
training increases the overall autonomic tone in subjects with VVS when compared to placebo. This 
pilot study has also demonstrated that, with minor modifications, a large scale randomized, placebo-
controlled study of this nature is both feasible and desirable. The significant improvements in 
autonomic parameters and positive trends in symptom improvements indicate that a future, 
adequately powered multi-centre, randomized placebo-controlled trial is now indicated as a matter 
of urgency.   
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FIGURE LEGENDS 
Figure 1. Study Design and Recruitment of Participants. 
HUT=head-up tilt-test; HOT=home orthostatic training 
 
Figure 2. Changes in Baroreflex Slope Over Baseline 
Mean change in log(Up Slope) and log(Down Slope) baroreflex slope over visits for HOT and 
placebo groups. Error bars represent standard errors about the mean. The individual values of up 
slope BRS and down slope BRS were first log-transformed before deriving the difference between 
each value at week 1, week 4 and week 24 from baseline.  
BRS=baroreflex slope.  
 
Figure 3. Changes in Heart Rate Variability Over Baseline. 
Mean change in log(LF) and log(HF) heart rate variability over visits for HOT and placebo groups. 
Error bars represent standard errors about the mean. The individual values of LF-HRV and HR-
HRV were first log-transformed before deriving the difference between each value at week 1, week 
4 and week 24 from baseline.  
LF=low frequency; HF= high frequency. 
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FIGURES 
Figure 1 
 
 
95 positive HUT 
25 (26%) inadequate 
symptoms 
70 (74%)  
2 syncope; 1 syncope + 3 
presyncope or 5 presyncope 
over 6 months 
16 (23%) met 
exclusion criteria 
54 (77%) invited to 
participate  
Exclusion 
< 18 years or no informed consent,  
can’t stand for 40 minutes,  
pregnancy,  
unable to discontinue medications 
22 (41%) 
randomized 
32 (59%) declined 
12 HOT therapy 10 sham training 
8 completed 
study 
1 withdrew 
1 lost to follow-up 
 
1 withdrew 
1 lost to follow-up 
 
10 completed 
study 
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TABLES 
Table 1  Characteristics of Participants.  
Characteristics 
Participants 
(n=22) 
Female [n (%)] 17 (77%) 
Age, yrs [mean (SD) ] 45 (20)  
Any occlusive vascular disease [n (%)] 1 (5%) 
Hypertension [n (%)] 5 (23%) 
Smoker [n (%)] 4 (18%) 
Alcohol [n (%)] 5 (23%) 
Vasoactive drugs* [n (%)] 4 (18%) 
Syncopal episodes in last 6 months 
[Median (quartile)] 
1 (0, 3) 
Presyncopal episodes in last 6 months 
[Median (quartile)] 
10 (1, 113) 
Baseline systolic blood pressure, mmHg 
[mean (SD)] 
130 (21) 
Baseline diastolic blood pressure , mmHg 
[mean (SD)] 
82(13) 
Baseline heart rate, bpm [mean (SD)] 74 (11) 
HUT=head-up tilt-table; SD=standard deviation. 
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*includes antihypertensive and antianginal medications Table 2. Changes in Autonomic Variables 
from Baseline Observed at Week 4 and Week 24. 
  Week 4/ Baseline Week 24/ Baseline 
  Mean 
ratio 
(SD) 
elog difference 
(95%CI) 
p-
value 
Mean 
ratio 
(SD) 
elog difference 
(95%CI) 
p-
value 
Up Slope 
BRS*  
 
HOT 1.34 
(1.90)  
1.59 (0.84, 
3.03) 
0.148 1.49 
(1.86) 
1.75 (1.01, 
3.06) 
0.047 
placebo 0.84 
(2.05) 
0.85 
(1.42) 
Down Slope 
BRS*  
 
HOT 1.48 
(1.82) 
1.79 (1.00, 
3.22) 
0.052 1.42 
(1.84) 
1.53 (0.88, 
2.68) 
0.148 
placebo 0.82 
(1.93) 
0.93 
(1.46) 
LF-HRV*  
 
HOT 1.70 
(2.66) 
3.22 (1.06, 
9.86) 
0.04 1.28 
(2.44) 
2.11 (0.72, 
6.17) 
0.159 
placebo 0.51 
(4.01) 
0.61 
(3.25) 
HF-HRV* 
 
HOT 2.01 
(1.97) 
3.19 (1.03, 
10.59 
0.045 1.57 
(4.36) 
2.13 (0.52, 
8.79) 
0.275 
placebo 0.61 
(5.37) 
0.74  
(3.14) 
*comparisons were made using log-transformed values. Antilog of mean and mean differences 
between log-transformed values is presented. The mean values with standard deviation therefore 
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represent the unitless ratio between week 4 over baseline and week 24 over baseline. The 
exponential value of the mean differences presented represents the ratios between the two groups. A 
lower confidence limit of >1, therefore, indicates significant difference.  
LF= low frequency; HF=high frequency; PSD=power spectral density; BRS=baroreflex sensitivity; 
HOT=home orthostatic training; elog difference= antilog of mean differences 
 
 
 
 
 
 
 
 
